According to our (Global Info Research) latest study, the global Companion Animal Cancer Screening Service market size was valued at US$ 241 million in 2025 and is forecast to a readjusted size of US$ 390 million by 2032 with a CAGR of 7.1% during review period.
Companion Animal Cancer Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management.
The market for cancer screening services for companion animals is primarily driven by factors such as the aging pet population, the rising incidence of tumors in dogs and cats, increased awareness among owners regarding health management, and continuous advancements in veterinary diagnostic technologies. As companion animals are increasingly viewed as integral family members, owners are placing greater emphasis on extending their pets' lifespans, improving their quality of life, and mitigating the risks associated with treating advanced-stage disease; this shift is driving the transition of cancer detection from diagnosing symptomatic cases to conducting routine screenings for geriatric animals, high-risk breeds, and seemingly healthy pets. Meanwhile, the maturation of technologies—including blood biomarkers, liquid biopsies, genetic sequencing, urinalysis, and AI-driven image analysis—has made cancer screening increasingly non-invasive, convenient, and suitable for inclusion in routine wellness check-ups. The expansion of screening services by veterinary hospitals, reference laboratories, and pet insurance providers, coupled with rising expenditure on pet healthcare, further supports market growth. However, factors such as diagnostic accuracy, sensitivity across different cancer types, standards for result interpretation, service pricing, and the processes for subsequent confirmatory diagnosis will continue to influence the pace of market adoption.
Report Scope
This report is a detailed and comprehensive analysis for global Companion Animal Cancer Screening Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Companion Animal Cancer Screening Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Companion Animal Cancer Screening Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Companion Animal Cancer Screening Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Companion Animal Cancer Screening Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Companion Animal Cancer Screening Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Companion Animal Cancer Screening Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IDEXX Laboratories, Antech Diagnostics, VolitionRx, Fujifilm, Zoetis Diagnostics, LABOKLIN, NationWide Laboratories, Midwest Vet Labs, VDI Laboratory, HT Vet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Companion Animal Cancer Screening Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
Blood-based Screening
Urine-based Screening
Others
Market segment by Cancer Coverage
Multi-cancer Screening Services
Single-cancer Screening Services
Cancer-group Screening Services
Market segment by Animal Type
Canine Cancer Screening Services
Feline Cancer Screening Services
Others
Market segment by Application
Routine Wellness Screening
Senior and High-Risk Animal Screening
Others
Market segment by players, this report covers
IDEXX Laboratories
Antech Diagnostics
VolitionRx
Fujifilm
Zoetis Diagnostics
LABOKLIN
NationWide Laboratories
Midwest Vet Labs
VDI Laboratory
HT Vet
Oncotect
PETcision
Bioguard Corporation
CanCan Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Companion Animal Cancer Screening Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Animal Cancer Screening Service, with revenue, gross margin, and global market share of Companion Animal Cancer Screening Service from 2021 to 2026.
Chapter 3, the Companion Animal Cancer Screening Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Companion Animal Cancer Screening Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Animal Cancer Screening Service.
Chapter 13, to describe Companion Animal Cancer Screening Service research findings and conclusion.
Summary:
Get latest Market Research Reports on Companion Animal Cancer Screening Service. Industry analysis & Market Report on Companion Animal Cancer Screening Service is a syndicated market report, published as Global Companion Animal Cancer Screening Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Companion Animal Cancer Screening Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.